Nilotinib efficacy and safety as salvage treatment following imatinib intolerance and/or inefficacy in steroid refractory chronic graft-versus-host-disease (SR-cGVHD): a prospective, multicenter, phase II study on behalf of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy
暂无分享,去创建一个
P. Chevallier | I. Yakoub-Agha | G. Guillerm | E. Forcade | J. Labreuche | V. Coiteux | Y. Beguin | Tamim Alsuliman | P. Turlure | C. Bulabois | S. François | L. Magro | É. Daguindau | M. Srour